News
‘Heartbroken and Thrown Into Tumultuous Grief and Shock’: Family Mourns Sudden Death of DJ Olie Bassweight “Something terrible” seemingly occurred to the musician.
Trump’s tariffs and the trade war continue to affect markets and the economy. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
On June 3, Wells Fargo increased the price target on The Pennant Group stock from $30 to $31, keeping its Equal Weight rating on the shares.
Trump’s tariffs and the trade war continue to affect markets and the economy. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
Andy Roddick isn't too high on Coco Gauff's Wimbledon chances as the American tennis legend thinks the world No. 2 won't even make the second week at The Championships.
“What the heck happened to the stock of Paychex today? Payroll processor and outsource human capital management company that cuts one out of every 11 paychecks in the private sector.
The market for weight management medicines has been the hottest therapeutic area in the past two years. Plenty of companies are now trying to make waves in this space.
However, recently, pharmaceutical giant Novo Nordisk, the maker of popular GLP-1 agonist weight loss drug Wegovy, terminated its sales partnership with the company due to its continued efforts to ...
Investing.com -- Edgewise Therapeutics Inc (NASDAQ: EWTX) stock tumbled 7.2% after the company revealed that the U.S. Food and Drug Administration (FDA) deemed its CANYON trial data insufficient ...
VK2375 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly 's blockbuster weight loss drug Zepbound. Viking is developing VK2375 in both subcutaneous (under the skin) and oral formulations.
Why I Believe Google Will Shock the Stock Market in 2025 June 24, 2025 — 07:00 am EDT Written by Jose Najarro for The Motley Fool -> ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results